Ribociclib plus Fulvestrant in Advanced Breast Cancer. Reply.

Slamon, Dennis J.; Jerusalem, Guy

doi:10.1056/NEJMc2004229

Request a copy

Article (Scientific journals)

Ribociclib plus Fulvestrant in Advanced Breast Cancer. Reply.

Slamon, Dennis J.; Jerusalem, Guy

2020 • In The New England journal of medicine, 382 (23), p. 85

Peer reviewed

Permalink
https://hdl.handle.net/2268/252362

DOI
10.1056/NEJMc2004229

PubMed
32492319

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Ribociclib plus fulvestrant in advanced breast cancer.pdf

Publisher postprint (59.07 kB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Aminopyridines; Breast Neoplasms; Fulvestrant; Humans; Purines; oncology

Disciplines :

Oncology

Author, co-author :

Slamon, Dennis J.

Jerusalem, Guy ; Université de Liège - ULiège > Département des sciences cliniques > Oncologie

Language :

English

Title :

Ribociclib plus Fulvestrant in Advanced Breast Cancer. Reply.

Publication date :

2020

Journal title :

The New England journal of medicine

ISSN :

0028-4793

eISSN :

1533-4406

Volume :

382

Issue :

Pages :

e85

Peer reviewed :

Peer reviewed

Available on ORBi :

since 10 November 2020

Statistics

Number of views

50 (2 by ULiège)

Number of downloads

2 (2 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations